Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers at the University of Oxford have developed a mindfulness training specifically for people with irritable bowel syndrome.

We are interested in finding out if this training is effective at reducing the symptoms of IBS and how the training achieves its effects. Interested? Please keep on reading to find out what is involved for you:

What is involved?

  • A six week mindfulness course
  • Regular study assessments

About the mindfulness course

Mindfulness for IBS is a new mindfulness course specifically for people with irritable bowel syndrome. The course consists of 6 x 2 hour group sessions over 6-7 weeks. During the course you will develop awareness of your mind and body through the cultivation of mindful awareness. The aim of the course is to reduce the symptoms of IBS and help you increase your mental and physical wellbeing.

Study Participation: The course is provided at no cost to you as participant

About the assessments

You will be asked to do 3 assessment visits at the Department of Experimental Psychology and 4-8 online questionnaires before, during and after the course. Each assessment visit takes 1-1.5 hours. Each questionnaire takes 30-45 minutes.

Are you eligible? 

  • Do you have a diagnosis of IBS?
  • Are you interested in trying mindfulness as a treatment for IBS?
  • Are you a woman between 18 and 65 years of age?

Location

Course: Oxford Mindfulness Centre, Oxford University

Assessments: Department of Experimental Psychology, Oxford University

Dates and Registration

To find out more about the study, when the courses take place and to register, please contact Julia Henrich via email Julia.Henrich@psy.ox.ac.uk.

You can also sign up online.

 

NHS REC Reference: REC: South Central – Oxford A, 15/SC/0618

Similar stories

Human challenge trial launches to study immune response to COVID-19

Clinical Trials Coronavirus COVID-19 General

Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time.

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.